Legal Information & Trademarks

Singular Genomics Systems, Inc.

Patents & Trademarks

At Singular Genomics Systems, Inc. (“Singular”), we thrive on continuous innovation, discovering and developing new technologies to bring ground-breaking products and systems to our markets. Our commercial success depends on our ability to develop, manufacture, market and sell our products and we rely on patent, trademark, copyright, trade secret, and other intellectual property rights and contractual restrictions to protect our proprietary products and technologies. 

Notice of Patents, Designs, and Similar Rights

In accordance with Section 287(a) of Title 35 of the United States Code (35 U.S.C. §287(a)), Section 62 of the UK Patents Act 1977, Section 49(1) of the Irish Patents Act 1992 and any other comparable requirements in other jurisdictions, notice is hereby given that Singular’s products are protected by a variety of intellectual property rights including issued patents and pending patent applications, registered designs, and similar rights, details of which are provided below: 




G4 Kits




Px Kits


Information on Trademarks and Service Marks (“Marks”)

The logos and names of Singular Genomics Systems, Inc. (“Singular”) products or services identified below are protected by U.S. and international trademark and copyright laws. All trademarks are the property of Singular and below is a non-exhaustive list of trademarks and service marks belonging to Singular.  Trademark symbols reflect the status of the mark in the United States. 



    Singular Genomics™

    Singular Genomics Branding







    Max Read™


    All trademark name represented and listed owners are believed to be accurate, but not guaranteed to be so.  Other third party trademarks referenced on this Site, including but not limited to those listed below, are the property of their respective owners:

    • Illumina and NextSeq are trademarks or registered trademarks of Illumina, Inc.

    Max Reads Application Note